Product Information
DESVENLAFAXINE SUCCNT ER 100 MG is a generic product labeled by NorthStar Rx LLC, priced at $0.4136 per EA under NDC 72603055701. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603055701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204028FDA Approved
6/29/2015
TE Code
AB
On Market Since
5/2/2025
Pharmacological Classes
Price Statistics
The NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4136 per EA |
|---|---|
| All-time high | $0.4475 (Dec 10, 2025) |
| All-time low | $0.4069 (Aug 19, 2026) |
| 52-week high | $0.4475 |
| 52-week low | $0.4069 |
| Median price | $0.4320 |
| Average price | $0.4306 |
| Largest weekly change | -2.9% (Feb 18, 2026) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DESVENLAFAXINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESVENLAFAXINE SUCCNT ER 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 100 MG, manufactured by NorthStar Rx LLC, is $0.4136 per EA (NDC 72603055701), effective Sep 30, 2026.
How has the price of DESVENLAFAXINE SUCCNT ER 100 MG changed over time?
Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has declined 6.0%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 100 MG?
Since Oct 1, 2025, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has ranged from a low of $0.4069 (Aug 19, 2026) to a high of $0.4475 (Dec 10, 2025), with a median of $0.4320 per EA.
Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 100 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 100 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures DESVENLAFAXINE SUCCNT ER 100 MG?
DESVENLAFAXINE SUCCNT ER 100 MG (NDC 72603055701) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.